A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo-HCT) with myeloablative (MAC; n=38) or reduced-intensity conditioning (RIC; n=110) regimens at MD Anderson Cancer Center were evaluated. should be conducted in carefully designed clinical trials in this patient population. Keywords: Multiple Myeloma, Allogenic transplant, Survival INTRODUCTION Absence of… Continue reading A total of 149 patients with multiple myeloma (MM) who received